Inocras
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
6330 Nancy Ridge Dr Ste 106, San Diego, ...Phone Number
+852 35116347Website
www.inocras.comRevenue
$7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Inocras
Founded in 2020 by a team of physician-scientists, geneticists, and bioinformaticians, the company's goal has been to improve how patients are diagnosed and treated by unlocking the full potential of genomic data. Since then, weve developed an IP-protected technology and proprietary whole genome insight platform while achieving operational excellence in the company's CLIA certified and CAP accredited lab.Explore more
Popular SearchesInocras IncInocrasInocras Hong Kong LtdSIC Code 87,873NAICS Code 54,541Show moreInocras Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Inocras your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Inocras has new funding data
Check if Inocras has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Inocras is spiking on competitors!
Inocras, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Inocras launches new products
Congratulate Masked Content for being promoted to Masked Content at Inocras
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Inocras recently announced quarterly report
Click to see if Inocras had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Inocras as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Inocras is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Inocras is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Inocras.
Inocras News & Media
Inocras and Center for Data Driven Discovery in Biomedicine Enter Collaborative Research Agreement to Advance Sinonasal Cancer Research
SAN DIEGO--(BUSINESS WIRE)--Today, Inocras announced the signing of a groundbreaking Collaborative Research Agreement with the Center for Data Driven Discovery in Biomedicine (D3b) to advance research into rare sinonasal cancers. Under the agreement, Inocras will conduct Whole Genome Sequencing (WGS) and bioinformatic analysis on rare sinonasal cancer samples provided by D3b. The leadership team at the Center for Data Driven Discovery in Biomedicine (D3b) - Phillip “Jay” Storm, Adam Resnick, anFore Genomics Partners with Inocras to Launch Pediatric Genetic Health Screening and Newborn Sequencing
SAN DIEGO--(BUSINESS WIRE)--Today, Fore Genomics, a leader in pediatric genetic health screening, announced a strategic partnership with Inocras, a leading innovator in whole genome sequencing (WGS) and AI-powered genetic analysis technologies, to enhance Fore’s proprietary pediatric and newborn health screening services. This collaboration marks a significant step towards improving early detection and intervention for a large number of pediatric-onset genetic conditions, with the initial rolloInocras earns ISO 15189 accreditation from ANSI ASQ National Accreditation Board (ANAB)
SAN DIEGO--(BUSINESS WIRE)--ANSI ASQ National Accreditation Board (ANAB) has awarded whole genome sequencing and bioinformatics company, Inocras Inc., accreditation to the ISO 15189 standard under its ISO 15189 Medical Laboratories Accreditation Program. Notably, Inocras is one of very few companies in the world with a CAP/CLIA/ISO 15189 accredited lab performing whole genome sequencing for cancer. This accreditation is based on the International Organization for Standardization (ISO) 15189 StaInocras and Summit Pharmaceuticals International Corporation Announce Collaboration Aim to Transform Clinical Genomics in Japan
SAN DIEGO--(BUSINESS WIRE)--Inocras Inc. (Head Office: 6330 Nancy Ridge Drive Suite 106 San Diego, CA 92121, President & CEO: Jehee Suh) (“Inocras”) and Summit Pharmaceuticals International Corporation (Head Office: Hitotsubashi, Chiyoda-ku, Tokyo, President & CEO: Katsuya Okuyama) (“SPI”) signed an MOU (Memorandum of understanding) to jointly explore the commercialization of their whole genome sequencing (WGS) analysis services. This collaboration aims to revolutionize healthcare
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Inocras
Sign Up For FreeTo access detailed company insights
Founded in 2020 by a team of physician-scientists, geneticists, and bioinformaticians, the company's goal has been to improve how patients are diagnosed and treated by unlocking the full potential of genomic data. Since then, weve developed an IP-protected technology and proprietary whole genome insight platform while achieving operational excellen... Read More
